Most patients experience onset between days 3 and 21 after their first injection or oral dose, with the highest incidence occurring during the first dose escalation phase
doi: 10.1097/MD.0000000000026295 235 HolstJJ
PubMed Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S., Perovic, D., Aralica, G., Zarkovic, N., Borovic, S., Srdjak, M., Hajdar, S., Kopljar, M., Batelja, L., Boban-Blagaic, A., Turcic, I., Amic, F., Ruenzi, E., Rucman, R., Seiwerth, S., & Sikiric, P
Abundant membrane transporters are key to allowing specific metabolites to enter and leave cells rapidly, according to their concentration gradient, moving from higher to lower concentration compartments (Figure 3)
Notas importantes : No se debe exceder la dosis diaria recomendada